Komodo Health, a US-based disease-tracking software provider backed by medical supplies distributor McKesson, has secured $50m in a series C round led by venture capital firm Andreessen Horowitz.
The round included Oak HC/FT and existing investors including fellow VC firms IA Ventures and Felicis Ventures. They took part in a series A round of undisclosed size for Komodo in 2016 alongside McKesson’s investment arm, McKesson Ventures.
Founded in 2014, Komodo is the creator of the Healthcare Map, a platform that utilises artificial intelligence to track the ongoing anonymised medical history of some 320 million patients, allowing users to decipher patterns from the data.
Arif Nathoo, co-founder and chief executive of Komodo Health, said: “Our platform is designed to drive better health outcomes for patients by harnessing the power of more than 320 million longitudinal healthcare experiences.
“Built on this wealth of knowledge, our technology delivers the insights needed to detect disparities in care delivery, identify interventions, and ultimately make a material difference in patient outcomes.”
The proceeds from the series C round have been earmarked for the expansion of Healthcare Map. Komodo Health has not revealed details of any series B financing.
